Next Article in Journal
Exclusive Breastfeeding Is Associated with Total Breastfeeding Duration and Growth Outcomes: Icelandic Mother and Child Health Study (ICE-MCH)
Previous Article in Journal
A Chimie Douce Route to Layered Double Hydroxides
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Silver–Chitosan Nanocomposites for Biomedical Application: Design, Synthesis and Antimicrobial Efficiency †

1
Laboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, 12618 Tallinn, Estonia
2
School of Science, Tallinn University of Technology, 19086 Tallinn, Estonia
*
Author to whom correspondence should be addressed.
Presented at the International Conference EcoBalt 2023 “Chemicals & Environment”, Tallinn, Estonia, 9–11 October 2023.
Proceedings 2023, 92(1), 40; https://doi.org/10.3390/proceedings2023092040
Published: 24 November 2023
(This article belongs to the Proceedings of International Conference EcoBalt 2023 "Chemicals & Environment")
Hospital-acquired infections are serious medical problems worldwide. Therefore, novel antimicrobials for the treatment of infections, especially those caused by antibiotic-resistant microbes, are urgently needed. We have previously shown that Ag, CuO and ZnO nanoparticles are also toxic against pathogenic microbes and relatively safe to animal cells [1], thus being promising for medical use, e.g., in wound treatment. Moreover, combining these NPs with biologically active polymers may enhance their efficacy and specificity. Chitosan (CS) is a biocompatible, antimicrobial and immuno-modulating polymer and is already used for wound treatments. Therefore, crosslinking chitosan with antimicrobial nanoparticles can yield novel antimicrobials with both biocidal and immune-modulating effects. The study aimed (i) to design and synthesize silver–chitosan nanocomposites (nAgCSs) with different silver–chitosan (Ag/CS) weight ratios (1:0.3, 1:1 and 1:3), (ii) to evaluate their efficacy against bacteria and fungi that can cause wound infections and (iii) to elucidate the mode of antimicrobial action of nAgCSs. nAgCSs were synthesized through the reduction of AgNO3 with trisodium citrate and stabilized/coated with low-molecular-weight chitosan. The antimicrobial activity of nAgCSs against bacteria Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus and fungi Candida albicans and C. glabrata was studied using a Spot test [2]. In this test, microbes are exposed to toxicants in deionized water for 1, 4 and 24 h and then plated on an agar medium for the quantification of the minimum biocidal concentration (MBC). The synthesized nAgCSs’ primary and hydrodynamic sizes were ~50 and ~100 nm, respectively, and the surface charge was ~+25 mV. The shedding of Ag ions was in the range of 2–4%. The synthesized nAgCSs were efficient antimicrobials acting already at sub-mg-per-litre concentrations. In general, the nAgCSs were more toxic towards bacteria than fungi (24-h MBC 0.07–0.56 and 9.3–44 mg Ag/L, respectively), and nAgCSs with an Ag/CS mass ratio of 1:3 were the most efficient. The high antimicrobial efficiency was most likely due to the absorption of nAgCSs onto the surface of the microbes, as shown via confocal laser scanning microscopy and flow cytometry. Interestingly, the shed Ag ions (the most reported toxicity mechanism of AgNPs) did not explain the biocidal effect of nAgCSs, indicating a synergy between chitosan and silver.

Author Contributions

Conceptualization, K.K. and A.K.; methodology, formal analysis and investigation, K.K.; J.L., M.S., H.V., I.K. and M.O.; writing, project administration and funding acquisition, K.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Estonian Research Council project PRG 749 and conducted using the NAMUR+ core facility (TT13).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Suppi, S.; Kasemets, K.; Ivask, A.; Künnis-Beres, K.; Sihtmäe, M.; Kurvet, I.; Aruoja, V.; Kahru, A. A novel method for comparison of biocidal properties of nanomaterials to bacteria, yeasts and algae. J. Hazard. Mater. 2015, 286, 75–84. [Google Scholar] [CrossRef] [PubMed]
  2. Bondarenko, O.; Juganson, K.; Ivask, A.; Kasemets, K.; Mortimer, M.; Kahru, A. Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: A critical review. Arch. Toxicol. 2013, 84, 1181–1200. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kasemets, K.; Laanoja, J.; Sihtmäe, M.; Vija, H.; Kurvet, I.; Otsus, M.; Kahru, A. Silver–Chitosan Nanocomposites for Biomedical Application: Design, Synthesis and Antimicrobial Efficiency. Proceedings 2023, 92, 40. https://doi.org/10.3390/proceedings2023092040

AMA Style

Kasemets K, Laanoja J, Sihtmäe M, Vija H, Kurvet I, Otsus M, Kahru A. Silver–Chitosan Nanocomposites for Biomedical Application: Design, Synthesis and Antimicrobial Efficiency. Proceedings. 2023; 92(1):40. https://doi.org/10.3390/proceedings2023092040

Chicago/Turabian Style

Kasemets, Kaja, Jüri Laanoja, Mariliis Sihtmäe, Heiki Vija, Imbi Kurvet, Maarja Otsus, and Anne Kahru. 2023. "Silver–Chitosan Nanocomposites for Biomedical Application: Design, Synthesis and Antimicrobial Efficiency" Proceedings 92, no. 1: 40. https://doi.org/10.3390/proceedings2023092040

Article Metrics

Back to TopTop